Active substanceTriamcinoloneTriamcinolone Similar drugsTo uncover Kenalog® pills inwards KRKA, dd, Novo mesto, AO Kenalog® suspension for injections Bristol-Myers Squibb Company Italy Kenalog® 40 suspension for injections KRKA, dd, Novo mesto, AO Polcortolone pills inwards Pabianicki Pharmaceutical Plant Polfa, JSC Poland Triacort® ointment externally AKRIKHIN HFK, JSC Russia Triamcinolone-FPO® pills inwards OBOLENSKOE PHARMACEUTICAL ENTERPRISE, CJSC Russia Fluorocort ointment externally GEDEON RICHTER, OJSC Hungary Dosage form: & nbspPills. Composition:One tablet contains: active ingredient: triamcinolone 4.0 mgauxiliary substances: potato starch - 144.2 mg, magnesium stearate - 1.8 mg, lactose - 200.0 mg. ATX: & nbspH.02.A.B.08 Triamcinolone Form release / dosage:Tablets 4 mg. Packaging:(25) - PVC / AL foil blister (2) / 25 tablets each in a PVC / Al foil blister. 2 blisters with instructions for use in a cardboard package. / - Cardboard tutu Storage conditions:Store in a dry, dark place at a temperature of no higher than 25 ° C. Keep out of the reach of children. Shelf life:3 years. Terms of leave from pharmacies:Without recipe Registration number:П N013540 / 01 Date of registration:12.12.2007 The owner of the registration certificate:Pabianicki Pharmaceutical Plant Polfa, JSCPabianicki Pharmaceutical Plant Polfa, JSC Poland Manufacturer: & nbspPABIANICE PHARMACEUTICAL WORKS POLFA Poland Representation: & nbspPABYNITSKY PHARMACEUTICAL FACTORY POLFA JSC PABYNITSKY PHARMACEUTICAL FACTORY POLFA JSC Poland Information update date: & nbsp24.09.2015 Illustrated instructions × Illustrated instructions Instructions